Amino Acid Synergy
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 9% of ingredients have research evidence
B
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
9%
Evidence Coverage
Supplement Facts — Evidence Check
14 mg
(700% DV)
📊 10.8× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
L-Histidine
338 mg
338 mg
📊 Market median: 17.4mg (161 products)
Alpha-Ketoglutarate
300 mg
300 mg
📊 Market median: 500.0mg (143 products)
300 mg
📊 Market median: 500.0mg (159 products)
L-Phenylalanine
300 mg
L-Valine
300 mg
270 mg
📊 Market median: 17.4mg (161 products)
270 mg
📊 Market median: 500.0mg (193 products)
📚 7 studies — no high-quality reviews
L-Threonine
270 mg
Other Ingredients
Microcrystalline Cellulose
Vegetable Stearate
Label Claims — Verification
❓
All Other
All Other (98% of products)
Structure/Function (78% of products)
Nutrient (56% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Product Information
📋 Directions for Use
Recommended Use: As a dietary supplement, take four capsules per day between meals, or as directed by your health care practitioner.
⚠️ Warnings & Precautions
KEEP OUT OF REACH OF CHILDREN.
🧪 Formulation Notes
Does not contain gluten.
Additional Information
AAS120
For Professional Use Only
Guaranteed GMP COMPLIANT Products
Manufactured in an NSF GMP Registered Facility
STORE IN A COOL, DRY PLACE.
Notice: Color, size or shape may appear different between lots.
Product Details
UPC / SKU
8 79452 00182 4
DSLD Entry Date
2013-06-25
Product Type
Other Combinations
Form
Capsule
Brand
Designs for Health
DSLD ID
22323
Data Updated
2026-04-11
Research Evidence
50
Research Sources
47
Avg Quality Score
28
Rct
13
Clinical Trial
5
Guideline
4
Systematic Review
A
Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
B
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
B
Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
B
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
B
[Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
B
Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
B
Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
C
Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Compare Similar Products
L-Tyrosine 500 mg
VitaCeutical Labs
100
Tyrosine
Vitabase
100
L-Tyrosine
Douglas Laboratories
100
L-Tyrosine 500 mg
Douglas Laboratories
100
N-Acetyl-L-Tyrosine 300
LifeLink
100